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There is a growing interest in diagnosis based on the analysis of saliva. This is a simple, non-invasive method of 
obtaining oral samples which is safe for both the health worker and the patient, not to mention allowing for simple 
and cost-efficient storage.
The majority of studies use general saliva samples in their entirety, complex fluids containing both local and 
systemic sources and whose composition corresponds to that of the blood. General saliva contains a considerable 
amount of desquamated epithelial cells, microorganisms and remnants of food and drink; it is essential to cleanse 
and refine the saliva samples to remove any external elements. Immediate processing of the sample is recommen-
ded in order to avoid decomposition, where this is not possible, the sample may be stored at -80ºC.
Salivary analysis – much the same as blood analysis – aims to identify diverse medication or indications of certain 
diseases while providing a relatively simple tool for both early diagnosis and monitoring various irregularities.
The practicalities of salivary analysis have been studied in fields such as: viral and bacterial infections, autoimmune 
diseases (like Sjögren’s syndrome and cɶliac disease), endocrinopathies (such as Cushing’s syndrome), oncology 
(early diagnosis of breast, lung and stomach carcinoma and oral squamous cell carcinoma), stress assessment, me-
dication detection and forensic science among others.
It is hoped that salivary analysis, with the help of current technological advances, will be valued much more highly 
in the near future. There still remain contradictory results with respect to analytic markers, which is why further 
studies into wider-ranging samples are fundamental to prove its viability.
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Introduction
There is a growing interest in diagnoses based on sali-
vary analysis given that collecting a sample of saliva is 
a simple, non-.invasive method. Collecting oral samples 
is safe for both the health worker and the patient, not to 
mention allowing for simple and cost-efficient storage. 
These characteristics make it possible to monitor various 
biomarkers in children, the elderly and for those patients 
who do not collaborate in taking blood or urine samples. 
Another reason as to why saliva is a useful diagnostic 
tool is that there is a direct relation between the basic 
biochemical parameters in both saliva and blood (1).
Collecting saliva and sample handling
There are two important aspects to take into account 
when taking a saliva sample which could influence the 
results: the type of saliva – whole or gland-specific sali-
va -, and the level of stimulation – stimulated or nonsti-
mulated saliva – (2).
In terms of this first aspect, the majority of studies (3-6) 
use general saliva; complex fluids containing both lo-
cal and systemic sources which could be utilised for 
the diagnosis of oral pathology, salivary gland patholo-
gy and systematic diseases. Whole saliva is a complex 
fluid drawn from each of the major and minor salivary 
glands and the mucosal and periodontal fibre and which 
is directly affected by oral factors such as oral health 
problems. Collecting whole saliva samples is simple and 
requires minimal equipment (7). Other authors (8) pre-
fer to collect saliva from one individual gland which, 
although being more difficult to collect and requiring 
more sophisticated equipment, it provides us with a 
more stable substance allowing for the retrieval of detai-
led information about diseases in specific glands thanks 
to the samples being less affected by the rest of the oral 
cavity (2). However, there are also authors who prefer to 
take samples of both types of saliva (9).
Whether the saliva is stimulated or nonstimulated is re-
flected in variable nature of the proportion of saliva in 
the major salivary glands and the concentration of cer-
tain proteins, ions and water. Nonstimulated saliva is 
considered to represent a neutral sample, less-affected 
by salivary glands, however it has also been suggested 
that stimulated saliva can allow for a more precise detec-
tion of cancer biomarkers. In cases of reduced salivary 
flow, like with Sjögren’s syndrome or after radiation the-
rapy, salivary stimulation may be required in order to 
obtain an optimum amount of saliva (2).
The fact that saliva may become altered due to physio-
logical processes which take place throughout the day 
and various oral stimulations must also be taken into ac-
count. In the majority of studies which have been carried 
out (3, 6, 8, 9) participants have been requested to avoid 
oral stimulate such as eating, drinking and oral hygie-
ne practises during a certain period before a sample is 
taken therefore establishing standard sample conditions 
due to the presence of circadian rhythms in saliva and 
their effect on the composition.
Given that general saliva contains a considerable 
amount of desquamated epithelial cells, microorganisms 
and remnants of food and drink; it is essential to clean-
se and refine the saliva samples to remove any external 
elements. Immediate processing of the sample is recom-
mended in order to avoid decomposition, where this is 
not possible, the sample may be stored at -80ºC (2).
Using saliva as a diagnostic fluid
There is a large amount of literature which describes the 
use of saliva, as well as gingival crevicular fluid and oral 
mucosal transudates to both monitor medication and 
also detect various oral and systematic diseases. Sali-
vary analysis, just like blood analysis, has two main ob-
jectives: to identify specific pathologies in patients and 
monitor change in those patients undergoing treatment 
(10).
The practicalities of salivary analysis have been studied 
in fields such as (Table 1):
Viral and bacterial infections.1. 
Autoimmune diseases: Sjögren’s syndrome and 2. 
cɶliac disease.
Endocrinopathies: Cushing’s syndrome.3. 
Oncology: oral squamous cell carcinoma.4. 
Cardiovascular diseases.5. 
Medicinal and drug testing.6. 
Forensic science.7. 
1. Viral and bacterial infections
The Helicobacter pylori infection is related to a multitu-
de of pathologies such as atrophic gastritis, gastric and 
duodenal ulcers and in some cases Mucosa Associated 
Lymphoid Tissue (MALT) lymphoma and gastric carci-
nomas. The oral cavity could become a reservoir for this 
type of pathogen, making a gastric reinfection possible 
(11, 12).
The study carried out by Medina and cols. (11) proved 
that H. pylori was in fact present in oral samples (plaque 
and saliva) from patients with digestive pathologies who-
se results from gastric biopsies confirmed the presence 
of the bacteria. What’s more, the study confirmed that 
H. pylori was more commonly found in the oral cavities 
of patients who suffered from gingivitis and periodontal 
disease, which could be the reason behind resistance to 
the antibiotic treatment.
Morales-Espinosa and cols. (12) point out that the pre-
sence of H. pylori in the oral cavity is related to gastroe-
sophageal disease and if accompanied by gastric symp-
toms, clear indications will be shown in the antibiotic 
treatment.
In 2007, Correia-Silvia y cols. (13) studied the presence 
of the cytomegalovirus (CMV) in saliva samples from 
124 patients who had undergone a hematopoietic stem 
cell transplant. The presence of the virus was detected 
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in all transplant patients whereas no trace of the virus 
was found in the specified healthy patients. The level of 
concentration of the virus was found to be at its highest 
100 days after the transplant. 
The authors reported that the state of immunosuppres-
sion in fact is likely to reactivate the virus, usually found 
within the oral mucosa, and that also the detection of 
CMV in saliva could be an extremely useful method for 
the early diagnosis of this infection.
2. Autoimmune diseases
Sjögren’s syndrome (SS)
Given that saliva is secreted directly from the salivary 
glands, analysis of salivary proteins in patients with SS 
is a promising area upon which to focus in the search of 
biomarkers for the disease. The analysis of proteins in 
saliva could also reveal biomarkers which differentiate 
primary and secondary variants of the syndrome (14). 
Biomarkers studied for the diagnosis of SS are nume-
rous (2, 3, 8, 9). Hu and cols. (15) have recently identi-
fied 24 antibodies which can differentiate patients with 
primary SS from patients with Systemic lupus erythe-
matosus and healthy patients. In addition, they assessed 
four salivary antibodies (anti-transglutaminase, anti-his-
tone, anti-SSA and anti-SSB in primary SS) in indepen-
dent patients and they were successfully assessed using 
ELISA, displaying the potential of microarrays of highly 
active proteins in the detection of salivary antibodies ac-
ting as biomarkers. These biomarkers could become a 
Pathology Author (year) Salivary marker
Infections:
- Viral: infection by CMV Correia- Silva (2007) CMV
- Bacterial: infection by H. 
pylori
Medina (2009) 
Morales- Espinosa (2009) 
H. pylori
Autoimmune diseases:




Albumin serum, actin, alpha-actin-1, Ig gamma-1 chain C region, 
B2-microglobulin, Ig receptor polimeryc salivary amylase, lysozyme 
C, carbonic anhydrase VI, cystatin C, polymeric Ig receptor, 
prolactin-inducible protein, cystatin SN, calgranulin A and B, fatty 
acids protein binding, anti-transglutaminase, anti-histone, anti-SSA 
and anti-SSB. 
- Cɶliac disease Pastore (2008)
Bonamico (2008, 2011)
Tissue anti-transglutaminase (TTG) antibodies
Endocrinopathies:





- Breast cancer Agha- Hossein (2009) Glucoprotein CA 15-3
- Lung cancer Xiao (2011) HP, AZGP1,  human calprotectin
- Gastric cancer Wu (2009) Proteins 6556.81 Da and 7081.17 Da
- OSCC Balicki (2005) epidermal growth factor
Rhodus (2005) IL-1, IL-6, IL-8, TNF-α
Mager (2005) Bacteria
Pickering (2007) ET-1
SahebJamee (2008) TNFα, IL-1α and IL-8
Wu (2010) - CD44, IL-1β, IL-8 and  calcium binding protein S100
- Antibodies against the p53 gene
- Promoter hypermethylation of the p16 gene







CMV: cytomegalovirus, H. pylori: Helicobacter pylori, ET-1: endothelin-1; OSCC: Oral squamous cell carcinoma, VEGF: vascular endothelial 
growth factor.
Table 1. Diagnostic use of saliva.
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clinical tool in the economic, non-invasive and simple 
detection of primary SS.
Cɶliac disease 
There are contradictory results concerning tests to detect 
the antibodies associated with the cɶliac disease (EC), 
and the definitive diagnosis continues to be based on an 
intestinal biopsy (16). However, according to certain 
studies, it might be possible to monitor the course of 
EC through the detection of tissue anti-transglutaminase 
(TTG) antibodies using the RBA (radio binding Assay) 
technique. Detecting these TTG antibodies could beco-
me a reliable, non-invasive easy procedure allowing us 
to monitor celiac patients on an adequate diet therefore 
avoiding the need for blood tests (4, 5).
3. Endocrinopathies
Some hormones usually measured in plasma, such as 
steroids, non-steroids, peptides and protein hormones 
can be detected in saliva. Before determining clinical 
reasons for the various levels of hormones in saliva, it 
is important to define the correlation between levels of 
serum. Perhaps detecting steroidal hormones may be 
the most interesting focus of studies on salivary hormo-
nes. The most frequently utilised biomarkers are: cor-
tisol, testosterone, dehydroepiandrosterone (DHEA), 
hydroxyprogesterone, progesterone and aldosterone (1).
Cushing’s syndrome
Cushing’s syndrome is one of the most difficult endo-
crinopathies to diagnose, and for this reason researchers 
around the world have a keen interest in discovering a 
more efficient early diagnostic method (17, 18). Diag-
nostic trials recommended by the Endocrine Society 
are: 24-hour urinary free cortisol, dexamethasone su-
ppression test – 1mg oral at night and late-night sali-
vary cortisol (17). Measuring cortisol in saliva is sim-
ple and reproducible and gives a reliable assessment of 
the hypothalamic-pituitary-adrenal axis (18). There are 
certain advantages with regards to cortisol serum tests, 
for example: the technique is simple, non-invasive and 
can be carried out in the patient’s home. For the reasons 
mentioned, the method is recommended in the treatment 
of children (1, 17).
Salivary cortisol is in equilibrium with free cortisol in 
plasma and unaffected by the salivary flow. Following 
recent recommendations from the Endocrine Society, 
two late-night salivary cortisol measurements are en-
couraged in order to filter out those patients with a sus-
pected hypercortisolism. It is also advised to measure 
salivary cortisol to study patients with cyclic Cushing’s 
syndrome and is it necessary to carry out a series of tests 
on paediatric patients.
Given all of the advantages mentioned, it is hoped that 
monitoring salivary cortisol will soon become a routine 
diagnostic method for Cushing’s syndrome.
4. Oncology
Validating markers for a variety of cancers such as breast 
cancer (19), lung cancer (20), gastric cancer (21) and 
oral squamous cell carcinoma (6, 22-28) among others, 
is an extremely important tool for early diagnosis and in 
turn a higher survival rate for cancer patients.
The first salivary biomarker for cancer to be discovered 
was the HER2/neu for breast cancer (26). CA 15-3 is 
a prognostic marker for breast cancer given that levels 
appear higher when compared to the results of healthy 
patients. Agha-Hosseini and cols. (19) discovered a po-
sitive correlation between serum and salivary levels for 
CA 15-3 in an inactive salivary flow. They also observed 
higher levels of this marker in untreated and advanced 
breast cancer cases.
In 2011, Xiao and cols. (20) came across a statistically 
significant overexpression of the protein markers HP, 
AZGP1 and human calprotectin in patients with lung 
cancer. Similarly, Wu and cols. (21) came across higher 
levels of the 6556.81 Da and 7081.17 Da proteins in the 
saliva of a group of 23 patients with gastric cancer com-
pared to healthy patients.
Oral Squamous Cell Carcinoma (OSCC)
The specific DNA and RNA of each tumour, just like the 
cells belonging to the lesion and inflammatory cells may 
be useful as markers of OSCC (26). Infections caused 
by microorganisms may also be implicated in the de-
velopment of OSCC. Mager and cols. (28) detected an 
increase in the salivary expression of Capnocytophaga 
gingivalis, Prevotella melaninogenica and Streptococ-
cus mitis in patients with OSCC compared with healthy 
patients.
An aberrant expression of CD44, IL-1β, IL-8 and cal-
cium binding protein S100 has been detected in both 
protein and genomic techniques. Implementing geno-
mic techniques we can observe promoter hypermethyla-
tion of the p16 gene in samples of serum and saliva. In 
addition, the DNA polymorphism of IL-1β, IL-6, IL-8, 
TNF-α and vascular endothelial growth factor (VEGF) 
has been associated with the development of OSCC. Au-
toantibodies against the p53 gene have been identified 
in samples of the saliva and serum of OSCC patients.
With the advances of nanotechnology applied to pro-
tein and genomic techniques, several markers of OSCC 
have been identified. However, more studies to confirm 
the specificity in larger sample sizes is most definitely 
required (26).
Along with OSCC patients, higher values of pro-infla-
mmatory cytokines (IL-1, IL-6, IL-8, TNF-α) have been 
discovered in saliva samples from patients with prema-
lignant lesions (with moderate or severe epithelial dys-
plasia) (27), and cytokine IL-8 in patients with periodon-
tal disease and autoimmune diseases (6). However, these 
levels are not as high as those in patients with carcinoma 
(6, 27). SahebJamee and cols. (25) did not find a signi-
ficant statistical increase of TNFα, IL-1α nor IL-8 in the 
saliva of OSCC patients yet it must be taken into account 
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that neither did they study a wide range of patients.
Balicki and cols. (22) observed a salivary increase in 
the epidermal growth factor (EGF) after head and neck 
cancer surgery which differed from the low levels of 
that marker before any cancer treatment took place. 
This is due to the fact that an over expression of EGF 
factors was detected in 75% of cancer patients. Picke-
ring and cols. (24) uncovered a salivary concentration 
more than 3.5 times greater in patients with OSCC of 
the peptide endothelin-1 (ET-1). Both authors concluded 
that more studies are needed to determine the effects of 
EGF and ET-1 in the development of OSCC.
5. Stress
The salivary enzyme amylase α (AAs) has been sug-
gested as a salivary marker which is sensitive to bodily 
changes in relation to stress (29, 30).
The physiological response to stress consists of activa-
ting the sympathetic nervous system whereas the paras-
ympathetic activity decreases. To assess this reaction, 
the direct determination of adrenaline and noradrenaline 
is extremely useful, for this reason AAs as a marker has 
been investigated (31). The AAs is an enzyme which 
hydrolyses glucose and maltose and which plays an im-
portant role in the oral phase of digestion aside from ha-
ving an antibacterial function (30).
A wide range of studies (29, 31-33) have shown an in-
crease in both this enzyme and in sympathetic function 
as a direct reaction to psychosocially and psychologica-
lly stressful situations. Due to this type of stimulus, an 
increase has also been found in the secretion of salivary 
proteins such as MUC7 mucin, lactoferrin and gene-
ral salivary proteins (32).
In short, depending on the stress stimuli, it has been pro-
ven that changes in this salivary enzyme are produced 
despite not yet understanding the biological meaning 
behind this phenomenon (30).
6. The detection of drugs and other medication
The use of saliva in drug and medication testing has 
grown and is replacing the traditional urine sample (34) 
(Table 2). The concentration of drugs such as ampheta-
mines, cocaine and some opiates in oral fluids are simi-
lar if not greater than in plasma (35) and in some cases 
drugs can appear in saliva before they appear in plasma 
(34).
Alcohol is most commonly detected in toxicology analy-
ses (35) especially in those connected to traffic accidents. 
The salivary concentration of ethanol is 9% greater com-
pared to plasma (36).
When smoked, nicotine has a direct effect on the oral 
cavity which is why tests to determine exposure to this 
substance include analysing metabolites cotinine and 
3-hydroxycotinine. The same effect is produced by 
cannabis which generally enters the organism by being 
smoked which explains why salivary levels are relati-
vely high even without activating salivary flow (34).
Cocaine can be detected in oral fluid after any kind of ad-
ministration, but more commonly after being smoked or 
inhaled. Salivary levels remain high up to an hour after 
administering the drug but decrease rapidly afterwards 
and are similar to levels found in the blood. Amphetami-
nes are detectable ten minutes after being taken and last 
up to 72 hours whereas methamphetamines are detecta-
ble around 500 minutes after being inhaled, smoked or 
ingested (34, 35). Levels of heroin in saliva are similar 
Substances Characteristics of salivary detection
Drugs
Alcohol The salivary concentration of ethanol is 9% greater compared to plasma.
Nicotine Checking for metabolites: cotinine and 3-hydroxycotinine saliva.
Cannabis Salivary THC is detectable very early and remains for up to 14h.
Cocaine Salivary levels remain high up to 1hour after administering the drug. Similar to blood 
levels.
Amphetamine Detectable 10 minutes after being administered and for up to 72hours after.
Methamphetamine Detectable in saliva up to 510 minutes after being inhaled, smoked and ingested.
Heroine Salivary levels similar to blood levels reaching max concentration after 2 minutes.
Medication
Barbiturates Highest salivary concentration 1h after administration and remaining stable for 50 
hours.
Benzodiazepines The nordiazepam, metabolite diazepam, appears in saliva 45 minutes after administra-
tion.
Codeine Detectable in saliva 1 hour after being taken; concentration in saliva 3-4 times greater 
than in plasma
Morphine Detectable in saliva soon after parenteral administration.
THC: tetrahidrocannabiol; mins: minutes; h: hour.
Table 2. Salivary detection of drugs and other medication (34-36).
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to levels in the blood and they are at a maximum just two 
minutes after being taken. These levels are greater if the 
heroin is smoked although around 30-60 minutes later 
they decrease reaching the values of peripheral blood 
(34).
There are few studies which analyse the presence of 
barbiturates and benzodiazepines in saliva due to their 
addictive nature. Higher concentrations of barbiturates 
have been found in saliva an hour after being admi-
nistered remaining stable for 50 hours. In order to mo-
nitor the levels of benzodiazepines in saliva, the drug 
diazepam has been chosen because it tends to be more 
frequently used; its metabolite, nordiazepam, has been 
shown to appear in saliva about 45 minutes after admi-
nistration (34).
Oral codeine will show up in saliva samples an hour after 
administration reaching a maximum concentration after 
1.6-1.7 hours. The concentration of codeine in saliva is 
3-4 times greater than in plasma (34, 35). Morphine is 
detectable in saliva shortly after parenteral administra-
tion; however traces can also show after smoking heroin 
or eating poppy seeds (34).
7. Forensic science
Another interesting use of salivary analysis is in foren-
sic science. Retrieving saliva, either directly from a sus-
pect or from the injuries sustained by the victim, can 
facilitate the analysis of the DNA. In order to collect a 
saliva sample cotton swabs are used. Even dried saliva 
from bite wounds suffered by the victim can be analysed 
using an amylase assay kit (36).
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